Manufacturer record
Swiss Garnier Biotech Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Swiss Garnier Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and June 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 23CCF050, Cyfolac* Forte (Prebiotic & Probiotics Capsules) (exp Nov 2022). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay. Listed in the June 2022 alert.
Records by type
4 records linked to Swiss Garnier Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cyfolac* Forte (Prebiotic & Probiotics Capsules) | Batch 23CCF050Mfg Jun 2021 · Exp Nov 2022 | AssayAssay | CDL KolkataCDSCO lab | Jun 2022 |
| STATIX -20 (Atorvastatin Tablets IP 20 mg) | Batch BPSB20093Mfg Aug 2020 · Exp Jul 2022 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2021 |
| Nitrobact-100 (Nitrofurantoin Capsules U.S.P.) | Batch A6JQS030Mfg Sep 2019 · Exp Aug 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2020 |
| PRICHEK-M 2 FORTE (Metformin Hydrochloride (SR) & Glimepiride Tablets) | Batch PFL1B83DMfg Feb 2018 · Exp Jan 2020 | Assay of GlimepirideAssay | CDL KolkataCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.